Join
Live feed
·
INSIDERFilingvia Quantisnow
Day One Biopharmaceuticals Inc. logo

COO, CFO AND SECRETARY York Charles N Ii converted options into 16,875 shares and sold $52,278 worth of shares (4,370 units at $11.96), increasing direct ownership by 5% to 252,638 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
DAWN· Day One Biopharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DAWN (Day One Biopharmaceuticals Inc.) and more on Quantisnow.

COO, CFO AND SECRETARY York Charles N Ii converted options into 16,875 shares and sold $52,278 worth of shares (4,370 units at $11.96), increasing direct ownership by 5% to 252,638 units (SEC Form 4) | Quantisnow